Therefore, it would be interesting to investigate whether IDO1 could deplete Trp, thereby activating the GCN2 pathway, which can be detected using C/EBP homologous protein (CHOP) as a marker [5], and upregulating VEGFA expression in glioma. Here, IDO1 is linked to central nervous system cancer.